Newsletter
Every new paper in this field, in your inbox.
Metabolic bariatric surgery markedly enhances glycemic control and liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). A scoping review of 14 studies reveals substantial reductions in fasting glucose, insulin resistance, and liver enzymes, alongside histological improvements, including decreased steatosis and fibrosis. These changes, observed…
A meta-analysis of 38,647 gastric bypass patients across 27 countries reveals robotic Roux-en-Y gastric bypass (rrygb) requires longer surgical time but offers improved intraoperative safety compared to laparoscopic Roux-en-Y (lrygb). Despite a significant increase in robotic surgeries from 0.2% to 5.7% over 25 years, both…
An international panel reached a consensus on sleeve gastrectomy, endorsing its use for diverse patient populations, including adolescents and the elderly. Key recommendations included avoiding routine dissection of the hiatus and prioritizing endoscopic pigtail drainage for managing acute leaks. Additional surgical options were outlined for…
One year post-bariatric surgery, 80% of patients showed a notable improvement in the nonalcoholic fatty liver disease (NAFLD) activity score. Nonalcoholic steatohepatitis (NASH) improved in 42.1% without worsening fibrosis, and 78.8% experienced fibrosis improvement. MRI-proton density fat fraction (MRI-PDFF) reliably detected liver fat remission in…
Bariatric surgery has significantly enhanced safety, evidenced by a 40% reduction in 90-day mortality over 15 years and declining severe complications. Among 486,161 procedures, sleeve gastrectomy and gastric bypass remain prevalent. However, improvements have plateaued since 2018, signaling a need for fresh optimization strategies. Notably,…
In a study involving 1,669 patients undergoing sleeve gastrectomy, staple-line leaks were significantly associated with low preoperative serum protein concentrations (spc). Patients with leaks had a median spc of 6.8 g/L compared to 7.1 g/L in those without leaks. Higher spc values reduced leak risk…
In a comprehensive study of 5,221 adults with obesity and chronic kidney disease (CKD), bariatric metabolic surgery (BMS) demonstrated a significantly reduced risk of major adverse cardiovascular events, major adverse kidney events, and all-cause mortality over five years. The protective effects of BMS were consistent…
Bariatric surgery yields substantial economic benefits, with total healthcare costs for surgical patients decreasing by an average of $5,677 compared to nonsurgical counterparts within two years. The study examined 18,864 adults, revealing a 22.6% reduction in costs, particularly among those with type 2 diabetes, steatohepatitis,…
Current findings highlight the efficacy of bariatric surgery in treating metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to steatohepatitis. The surgical interventions, including Roux-en-Y gastric bypass and sleeve gastrectomy, significantly enhance liver outcomes by reducing steatosis, inflammation, and fibrosis, while lowering cancer risk.…
A novel procedure, reversible endoscopic gastroduodenal bypass (REGB), demonstrated 100% technical success in six patients with persistent post-surgical duodenal leaks. Patients experienced significant reductions in drain output and resumed oral intake within three days. Following a mean of 52.6 days, five patients successfully underwent REGB…
